Related Experiment Video
Updated: Aug 23, 2025
A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
Published on: March 15, 2016
VEGF Immunoexpression in Endometrioid Endometrial Carcinomas
Ileana Drocaş1, Ştefania Crăiţoiu2, Alex Emilian Stepan3
1PhD Student, Department of Histology, University of Medicine and Pharmacy of Craiova, Romania.
Vascular endothelial growth factor (VEGF) fuels endometrial cancer growth. High VEGF levels correlate with more aggressive endometrial cancer, suggesting it as a therapeutic target.
Area of Science:
- Oncology
- Pathology
- Angiogenesis Research
Background:
- Endometrial cancer remains a significant cause of mortality.
- Tumor angiogenesis, stimulated by VEGF, is crucial in cancer progression.
- VEGF is a potential therapeutic target for endometrial cancer.
Purpose of the Study:
- To investigate VEGF immunoexpression in endometrial cancer.
- To correlate VEGF levels with histopathological indicators of tumor aggressiveness.
Main Methods:
- Analysis of VEGF immunoexpression in 50 endometrial cancer cases.
- Correlation with tumor grade, stage, myometrial invasion, invasion patterns, and vascular invasion.
Main Results:
- High VEGF scores were associated with high grade and advanced stage endometrial cancer.
- VEGF expression was not significantly related to myometrial invasion depth, invasion pattern, or vascular invasion.
- VEGF immunoexpression may indicate tumor angiogenic potential.
Conclusions:
- VEGF immunoexpression is linked to endometrial cancer aggressiveness.
- VEGF may serve as a biomarker for assessing tumor angiogenic potential.
- VEGF warrants further investigation as a target for specific antitumor therapies.
More Related Videos
07:46Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells
Published on: October 13, 2023
05:30Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis
Published on: November 8, 2024